IQVIA Holdings Inc. (LON:0JDM)
London · Delayed Price · Currency is GBP · Price in USD 231.30
+2.29 (1.00%)
At close: Nov 28, 2025
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of 29.59 billion as of November 28, 2025. Its market cap has decreased by -2.68% in one year.
Market Cap
29.59B
Enterprise Value
39.71B
Revenue
11.83B
Ranking
n/a
PE Ratio
31.00
Stock Price
231.30
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from 3.50B to 29.59B, an increase of 744.91%. That is a compound annual growth rate of 18.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 29.59B | 3.87% |
| Dec 31, 2024 | 28.49B | -14.06% |
| Dec 29, 2023 | 33.15B | 4.96% |
| Dec 30, 2022 | 31.58B | -20.65% |
| Dec 31, 2021 | 39.81B | 58.21% |
| Dec 31, 2020 | 25.16B | 11.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.29B |
| GSK plc | 72.40B |
| Haleon | 32.95B |
| Smith & Nephew | 10.67B |
| ConvaTec Group | 4.60B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.74B |